The microbiota–gut–brain axis in obesity

The Lancet Gastroenterology and Hepatology

Volumn 2, Issue 10, 2017, Pages 747-756

  Torres Fuentes, Cristina ^a   Schellekens, Harriët ^a,b   Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; FARNESOID X RECEPTOR; GHRELIN; GLUTAMIC ACID; PREBIOTIC AGENT; PROBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; APPETITE; BACTERIAL OVERGROWTH; BEHAVIOR DISORDER; BIFIDOBACTERIUM; BIOCHEMICAL ANALYSIS; BODY MASS; BRAIN; DIABETES MELLITUS; ENDOTOXEMIA; FOOD INTAKE; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE FLORA; LACTOBACILLUS; LIVER FUNCTION; METABOLIC SYNDROME X; MICROBIAL DIVERSITY; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SEROTONIN METABOLISM; STRESS; VAGUS NERVE STIMULATION; WEIGHT GAIN; AFFECT; ENERGY METABOLISM; FECAL MICROBIOTA TRANSPLANTATION; FEEDING BEHAVIOR; HUMAN; LOW CALORY DIET; METABOLISM; METAGENOMICS; PSYCHOLOGY; REWARD;

AFFECT; APPETITE REGULATION; BRAIN; DIET, REDUCING; ENERGY METABOLISM; FECAL MICROBIOTA TRANSPLANTATION; FEEDING BEHAVIOR; GASTROINTESTINAL MICROBIOME; HUMANS; METAGENOMICS; OBESITY; PREBIOTICS; PROBIOTICS; REWARD;

EID: 85031869364     PISSN: 24681253     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2468-1253(17)30147-4     Document Type: Review

References (105)

1. Ottman, N, Smidt, H, de Vos, WM, Belzer, C, The function of our microbiota: who is out there and what do they do?. Front Cell Infect Microbiol, 2, 2012, 104.
2. Eckburg, PB, Bik, EM, Bernstein, CN, et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
3. Patterson, E, Ryan, PM, Cryan, JF, et al. Gut microbiota, obesity and diabetes. Postgrad Med J 92 (2016), 286–300.
4. Dinan, TG, Cryan, JF, Mood by microbe: towards clinical translation. Genome Med, 8, 2016, 36.
5. Neufeld, KA, Kang, N, Bienenstock, J, Foster, JA, Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol 4 (2011), 492–494.
6. Bäckhed, F, Ding, H, Wang, T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101 (2004), 15718–15723.
7. Turnbaugh, PJ, Ley, RE, Mahowald, MA, Magrini, V, Mardis, ER, Gordon, JI, An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
8. Khan, MJ, Gerasimidis, K, Edwards, CA, Shaikh, MG, Role of gut microbiota in the aetiology of obesity: proposed mechanisms and review of the literature. J Obes, 2016 published online Sept 15. DOI:10.1155/2016/7353642.
9. Fetissov, SO, Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour. Nat Rev Endocrinol 13 (2016), 11–25.
10. Cox, LM, Yamanishi, S, Sohn, J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158 (2014), 705–721.
11. Aron-Wisnewsky, J, Clement, K, The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity. Curr Atheroscler Rep, 16, 2014, 454.
12. Zhang, H, DiBaise, JK, Zuccolo, A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 106 (2009), 2365–2370.
13. Liou, AP, Paziuk, M, Luevano, JM Jr, Machineni, S, Turnbaugh, PJ, Kaplan, LM, Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med, 5, 2013, 178ra41.
14. Bloom, SR, Kuhajda, FP, Laher, I, et al. The obesity epidemic: pharmacological challenges. Mol Interv 8 (2008), 82–98.
15. O'Neill, S, O'Driscoll, L, Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev 16 (2015), 1–12.
16. Sandhu, KV, Sherwin, E, Schellekens, H, Stanton, C, Dinan, TG, Cryan, JF, Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl Res 179 (2016), 223–244.
17. Duca, FA, Swartz, TD, Sakar, Y, Covasa, M, Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS One, 7, 2012, e39748.
18. Ley, RE, Bäckhed, F, Turnbaugh, P, Lozupone, CA, Knight, RD, Gordon, JI, Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102 (2005), 11070–11075.
19. Turnbaugh, PJ, Gordon, JI, The core gut microbiome, energy balance and obesity. J Physiol 587 (2009), 4153–4158.
20. Turnbaugh, PJ, Ley, RE, Mahowald, MA, Magrini, V, Mardis, ER, Gordon, JI, An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
21. Ridaura, VK, Faith, JJ, Rey, FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
22. Sze, MA, Schloss, PD, Looking for a signal in the noise: revisiting obesity and the microbiome. MBio 7 (2016), e01018–e01020.
23. Ussar, S, Griffin, NW, Bezy, O, et al. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab 22 (2015), 516–530.
24. Goodrich, JK, Waters, JL, Poole, AC, et al. Human genetics shape the gut microbiome. Cell 159 (2014), 789–799.
25. Liu, R, Hong, J, Xu, X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med, 2017 published online June 19. DOI:10.1038/nm.4358.
26. Zhang, LS, Davies, SS, Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med, 8, 2016, 46.
27. Krajmalnik-Brown, R, Ilhan, ZE, Kang, DW, DiBaise, JK, Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract 27 (2012), 201–214.
28. Murphy, EF, Cotter, PD, Healy, S, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59 (2010), 1635–1642.
29. Boulange, CL, Neves, AL, Chilloux, J, Nicholson, JK, Dumas, ME, Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med, 8, 2016, 42.
30. Bäckhed, F, Manchester, J, Semenkovich, C, Gordon, J, Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104 (2007), 979–984.
31. Ridlon, JM, Kang, DJ, Hylemon, PB, Bajaj, JS, Bile acids and the gut microbiome. Curr Opin Gastroenterol 30 (2014), 332–338.
32. Thomas, C, Gioiello, A, Noriega, L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10 (2009), 167–177.
33. Zhang, Y, Ge, X, Heemstra, LA, et al. Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice. Mol Endocrinol 26 (2012), 272–280.
34. Trabelsi, MS, Lestavel, S, Staels, B, Collet, X, Intestinal bile acid receptors are key regulators of glucose homeostasis. Proc Nutr Soc 16 (2016), 1–11.
35. Staels, B, Fonseca, BA, Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration. Diabetes Care 32 (2009), S237–S245.
36. O'Mahony, SM, Clarke, G, Borre, YE, Dinan, TG, Cryan, JF, Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277 (2015), 32–48.
37. Nonogaki, K, Kaji, T, Pharmacological stimulation of serotonin 5-HT1B receptors enhances increases in plasma active glucagon-like peptide-1 levels induced by dipeptidyl peptidase-4 inhibition independently of feeding in mice. Diabetes Metab 41 (2015), 425–428.
38. Dumas, ME, Barton, RH, Toye, A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103 (2006), 12511–12516.
39. Parseus, A, Sommer, N, Sommer, F, et al. Microbiota-induced obesity requires farnesoid X receptor. Gut 66 (2017), 429–437.
40. Delzenne, NM, Neyrinck, AM, Bäckhed, F, Cani, PD, Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7 (2011), 639–646.
41. Rooks, MG, Garrett, WS, Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16 (2016), 341–352.
42. Schellekens, H, Dinan, TG, Cryan, JF, Lean mean fat reducing “ghrelin” machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology 58 (2010), 2–16.
43. Abbott, CR, Monteiro, M, Small, CJ, et al. The inhibitory effects of peripheral administration of peptide YY(3–36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044 (2005), 127–131.
44. Berthoud, HR, The vagus nerve, food intake and obesity. Regul Pept 149 (2008), 15–25.
45. Bodenlos, JS, Schneider, KL, Oleski, J, Gordon, K, Rothschild, AJ, Pagoto, SL, Vagus nerve stimulation and food intake: effect of body mass index. J Diabetes Sci Technol 8 (2014), 590–595.
46. Everard, A, Cani, PD, Gut microbiota and GLP-1. Rev Endocr Metab Disord 15 (2014), 189–196.
47. Torres-Fuentes, C, Schellekens, H, Dinan, TG, Cryan, JF, A natural solution for obesity: bioactives for the prevention and treatment of weight gain. A review. Nutr Neurosci 18 (2015), 49–65.
48. Cani, PD, Everard, A, Duparc, T, Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol 13 (2013), 935–940.
49. Nohr, MK, Pedersen, MH, Gille, A, et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154 (2013), 3552–3564.
50. Frost, G, Sleeth, ML, Sahuri-Arisoylu, M, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun, 5, 2014, 3611.
51. Perry, RJ, Peng, L, Barry, NA, et al. Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature 534 (2016), 213–217.
52. Calvo, SS, Egan, JM, The endocrinology of taste receptors. Nat Rev Endocrinol 11 (2015), 213–227.
53. Swartz, TD, Duca, FA, de Wouters, T, Sakar, Y, Covasa, M, Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota. Br J Nutr 107 (2012), 621–630.
54. Wall, R, Cryan, JF, Ross, RP, Fitzgerald, GF, Dinan, TG, Stanton, C, Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol 817 (2014), 221–239.
55. Meng, F, Han, Y, Srisai, D, New inducible genetic method reveals critical roles of GABA in the control of feeding and metabolism. Proc Natl Acad Sci USA 113 (2016), 3645–3650.
56. Delgado, TC, Glutamate and GABA in appetite regulation. Front Endocrinol (Lausanne), 4, 2013, 103.
57. Heisler, LK, Jobst, EE, Sutton, GM, et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51 (2006), 239–249.
58. Xu, Y, Jones, JE, Kohno, D, et al. 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron 60 (2008), 582–589.
59. Cani, PD, Plovier, H, Van Hul, M, et al. Endocannabinoids—at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol 12 (2016), 133–143.
60. Jager, G, Witkamp, RF, The endocannabinoid system and appetite: relevance for food reward. Nutr Res Rev 27 (2014), 172–185.
61. Schellekens, H, Finger, BC, Dinan, TG, Cryan, JF, Ghrelin signalling and obesity: at the interface of stress, mood and food reward. Pharmacol Ther 135 (2012), 316–326.
62. Byrne, CS, Chambers, ES, Alhabeeb, H, et al. Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods. Am J Clin Nutr 104 (2016), 5–14.
63. Collins, SM, Kassam, Z, Bercik, P, The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol 16 (2013), 240–245.
64. Kelly, JR, Borre, Y, O'Brien, C, et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 82 (2016), 109–118.
65. Bruce-Keller, AJ, Salbaum, JM, Luo, M, et al. Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol Psychiatry 77 (2015), 607–615.
66. Sudo, N, Chida, Y, Aiba, Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558 (2004), 263–275.
67. Dinan, TG, Cryan, JF, Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol 595 (2017), 489–503.
68. Burokas, A, Arboleya, S, Moloney, RD, et al. Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry, 2017 published online Feb 24. DOI:10.1016/j.biopsych.2016.12.031.
69. Bravo, JA, Forsythe, P, Chew, MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108 (2011), 16050–16055.
70. Borre, YE, O'Keeffe, GW, Clarke, G, Stanton, C, Dinan, TG, Cryan, JF, Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 20 (2014), 509–518.
71. Zhang, C, Zhang, M, Wang, S, et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 4 (2010), 232–241.
72. De Filippo, C, Cavalieri, D, Di Paola, M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107 (2010), 14691–14696.
73. Sonnenburg, ED, Smits, SA, Tikhonov, M, Higginbottom, SK, Wingreen, NS, Sonnenburg, JL, Diet-induced extinctions in the gut microbiota compound over generations. Nature 529 (2016), 212–215.
74. Turnbaugh, P, Bäckhed, F, Fulton, L, Gordon, J, Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
75. O'Toole, PW, Jeffery, IB, Gut microbiota and aging. Science 350 (2015), 1214–1215.
76. Claesson, MJ, Jeffery, IB, Conde, S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
77. Thaiss, CA, Itav, S, Rothschild, D, et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature 540 (2016), 544–551.
78. Slavin, J, Fiber and prebiotics: mechanisms and health benefits. Nutrients 5 (2013), 1417–1435.
79. Graf, D, Di Cagno, R, Fak, F, et al. Contribution of diet to the composition of the human gut microbiota. Microb Ecol Health Dis, 26, 2015, 26164.
80. Bindels, LB, Delzenne, NM, Cani, PD, Walter, J, Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 12 (2015), 303–310.
81. Sonnenburg, JL, Bäckhed, F, Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
82. Conlon, MA, Bird, AR, The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7 (2015), 17–44.
83. Caesar, R, Tremaroli, V, Kovatcheva-Datchary, P, Cani, PD, Backhed, F, Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 22 (2015), 658–668.
84. Cardona, F, Andres-Lacueva, C, Tulipani, S, Tinahones, FJ, Queipo-Ortuno, MI, Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem 24 (2013), 1415–1422.
85. Amiot, MJ, Riva, C, Vinet, A, Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review. Obes Rev 17 (2016), 573–586.
86. Ozdal, T, Sela, DA, Xiao, J, Boyacioglu, D, Chen, F, Capanoglu, E, The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients, 8, 2016, 78.
87. Conlon, LE, Wallig, MA, Erdman, JW Jr, Low-lycopene containing tomato powder diet does not protect against prostate cancer in TRAMP mice. Nutr Res 35 (2015), 882–890.
88. David, LA, Maurice, CF, Carmody, RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
89. Cox, LM, Blaser, MJ, Opinion antibiotics in early life and obesity. Nat Rev Endocrinol 11 (2015), 182–190.
90. Chassaing, B, Koren, O, Goodrich, JK, et al. Corrigendum: dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519 (2015), 92–96.
91. Suez, J, Korem, T, Zeevi, D, Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514 (2014), 181–186.
92. Dominguez-Bello, MG, Costello, EK, Contreras, M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107 (2010), 11971–11975.
93. Thavagnanam, S, Fleming, J, Bromley, A, Shields, MD, Cardwell, CR, A meta-analysis of the association between caesarean section and childhood asthma. Clin Exp Allergy 38 (2008), 629–633.
94. Pistiner, M, Gold, DR, Abdulkerim, H, Hoffman, E, Celedon, JC, Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy. J Allergy Clin Immunol 122 (2008), 274–279.
95. Huh, SY, Rifas-Shiman, SL, Zera, CA, et al. Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study. Arch Dis Child 97 (2012), 610–616.
96. Sevelsted, A, Stokholm, J, Bonnelykke, K, Bisgaard, H, Cesarean section and chronic immune disorders. Pediatrics, 2015 published online Dec 1. DOI:10.1542/peds.2014-0596.
97. Cryan, JF, Dinan, TG, Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13 (2012), 701–712.
98. WHO, FAO. Probiotics in food. Health and nutritional properties and guidelines for evaluation. http://www.fao.org/3/a-a0512e.pdf, 2006 (accessed April 1, 2017).
99. Everard, A, Belzer, C, Geurts, L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110 (2013), 9066–9071.
100. Khoruts, A, Sadowsky, MJ, Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol 13 (2016), 508–516.
101. Li, SS, Zhu, A, Benes, V, Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352 (2016), 586–589.
102. Li, YT, Cai, HF, Wang, ZH, Xu, J, Fang, JY, Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for clostridium difficile infection. Aliment Pharmacol Ther 43 (2016), 445–457.
103. Vrieze, A, Van Nood, E, Holleman, F, Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916 e7.
104. Alang, N, Kelly, CR, Weight gain after fecal microbiota transplantation. Open Forum Infect Dis, 2, 2015, ofv004.
105. Marotz, CA, Zarrinpar, A, Treating obesity and metabolic syndrome with fecal microbiota transplantation. Yale J Biol Med 89 (2016), 383–388.